Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Aquis AQSE - Delayed Quote GBp

ProBiotix Health Plc (PBX.AQ)

Compare
12.23
+0.03
+(0.20%)
As of 2:00:22 PM GMT. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
NameTitlePayExercisedYear Born
Mr. Steen Dannemann Andersen CEO & Director 250.71k -- 1963
Mr. Cellan Davies Head of Marketing -- -- --
Mr. Mark Kingsley Collingbourne Secretary -- -- 1966

ProBiotix Health Plc

First Floor Zucchi Suite
Nostell Business Estate
Wakefield, WF4 1AB
United Kingdom
https://probiotixhealth-ir.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
7

Description

ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. It offers YourBiotix CH and InstaMelt, capsule formula which contains LPLDL for maintenance of healthy cholesterol; YourBiotix BP, a blood pressure-reducing tablet formula for hypertension and cardiovascular health; and YourBiotix VH, a vascular health capsule formula, indicated to work against the build-up of lipid and calcium deposits in the blood vessels. The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in February 2022. The company was incorporated in 2021 and is based in Wakefield, the United Kingdom.

Corporate Governance

ProBiotix Health Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

OPTI.L OptiBiotix Health Plc
18.48
+1.26%
 
SBTX.L SkinBioTherapeutics plc
19.95
-0.77%
 
TYPTF
0.0112
0.00%
 
OBI.L Ondine Biomedical Inc.
10.48
-10.47%
 
GNS.L Genus plc
1,816.00
-1.41%
 
ELTX Elicio Therapeutics, Inc.
8.31
+0.48%
 
HVO.L hVIVO plc
16.22
-1.69%
 
NEUP Neuphoria Therapeutics Inc.
5.20
+0.19%
 
SNGX Soligenix, Inc.
2.3100
+2.67%
 
PPCB Propanc Biopharma, Inc.
6.75
0.00%